North America Pharmaceutical Logistics Market Size, Share, and COVID-19 Impact Analysis, By Product (Generic Drugs and Branded Drugs), By Application (Bio Pharma, Chemical Pharma, and Specialized Pharma), and North America Pharmaceutical Logistics Market Insights, Industry Trend, Forecasts to 2035

North America Pharmaceutical Logistics Market Insights Forecasts to 2035

• The North America Pharmaceutical Logistics Market Size Was Estimated at USD 2.35 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of Around 5.5 % from 2025 to 2035
• The North America Pharmaceutical Logistics Market Size is Expected to Reach USD 130.60 Billion by 2035

According to a research report published by Spherical Insights & Consulting, The North America Pharmaceutical Logistics Market Size is anticipated to reach USD 130.60 billion by 2035, growing at a CAGR of 5.5 % from 2025 to 2035. Technological developments, the growing demand for temperature-sensitive medications, the growth of e-commerce, regulatory backing, and a greater emphasis on supply chain efficiency and resilience all create opportunities for the North America pharmaceutical logistics market.

Market Overview

The comprehensive network of infrastructure, services, and technology devoted to the processing, storage, and transportation of pharmaceutical products throughout the Northwest is known as the North America pharmaceutical logistics market. The safe, effective, and legal transportation of expensive, temperature-sensitive medical products, such as vaccines, biologics, and prescription drugs, across the supply chain is guaranteed by North America pharmaceutical logistics market. Cold chain logistics, warehousing, inventory control, and last-mile delivery are all included, and they are all subject to strict regulations set by organizations like Health Canada and the U.S. Food and Drug Administration (FDA).  

The expanding worldwide pharmaceutical trade, the growing demand for temperature-sensitive medications and biologics, and the growth of e-commerce in the healthcare industry are the main factors propelling the North America pharmaceutical logistics market. Increased use of track-and-trace technologies, stricter drug safety regulations, and improvements in cold chain logistics all contribute to the market's expansion. The need for pharmaceutical logistics is anticipated to be driven by a number of significant factors, including a growing preference for biological drugs in recent years and an increase in the number of businesses choosing to outsource.

Report Coverage

This research report categorizes the market for North America pharmaceutical logistics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America pharmaceutical logistics market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the North America pharmaceutical logistics market. 

Driving Factors

The pharmaceutical logistics sector is expanding as a result of the rising demand for over-the-counter (OTC) medications, including vitamins, minerals, supplements, gastrointestinal medications, and cold treatments. The market is expanding as a result of both the increased need for fast-track support and the rising demand for home healthcare solutions. One of the main factors propelling the expansion of cold chain logistics for the pharmaceutical sector is the increase in demand for pharmaceuticals.  Increased demand for biological medical products and temperature-sensitive drugs, along with increased awareness among pharmaceutical and logistics companies, are broadening the scope of temperature-controlled pharmaceutical logistics and fostering the expansion of the pharmaceutical logistics market. 

Restraining Factors

The North American pharmaceutical logistics market is restricted by reasons such as strict regulatory compliance, high operating costs, difficulties managing temperature-sensitive products, and a lack of infrastructure in distant places, which make it difficult to have a seamless supply chain that is both efficient and scalable.

Market Segmentation

The North America pharmaceutical logistics market share is classified into product and application.  

• The branded drugs segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

The North America pharmaceutical logistics market is segmented by product into generic drugs and branded drugs. Among these, the branded drugs segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. These medications are produced and marketed under the names of pharmaceutical companies' branded pharmaceuticals section. Branded drugs are protected by patents, which give the manufacturer the exclusive right to make and sell the drug for a set period of time.    

• The bio pharma segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The North America pharmaceutical logistics market is segmented by application into bio pharma, chemical pharma, and specialized pharma. Among these, the bio pharma segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing popularity of biopharma in the pharmaceutical industry and its ability to treat ailments with little to no side effects are partly responsible for the Chemical Pharma category.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the North America pharmaceutical logistics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

List of Key Companies

• Deutsche Post DHL
• FedEx
• CEVA Logistics
• DB Schenker
• Air Canada
• Agility Logistics
• C.H. Robinson Worldwide Inc.
• United Parcel Service Inc.
• Kuehne + Nagel International AG
• Others

Key Target Audience 

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In January 2025, Inmar Supply Chain Solutions, a part of Inmar Intelligence and a top supplier of returns solutions for the retail e-commerce sector, was acquired by DHL Supply Chain. DHL Supply Chain will become the biggest supplier of reverse logistics solutions in North America as a result of the strategic acquisition.   

Market Segment

This study forecasts revenue at North America, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the North America pharmaceutical logistics market based on the below-mentioned segments:

North America Pharmaceutical Logistics Market, By Product

• Generic Drugs
• Branded Drugs

North America Pharmaceutical Logistics Market, By Application

• Bio Pharma
• Chemical Pharma
• Specialized Pharma